Is Sanfilippo Syndrome hereditary?

TL;DR: Sanfilippo Syndrome is a genetic, autosomal recessive condition, meaning it is hereditary and passed down from parents to children through specific gene mutations. It is not caused by external factors, and there is a 25% chance of recurrence in each pregnancy for parents who are both carriers of the mutated gene.

Is Sanfilippo Syndrome hereditary?

Yes, Sanfilippo Syndrome (also known as Mucopolysaccharidosis Type III or MPS III) is a strictly genetic, hereditary disorder. It is caused by mutations in one of four specific genes (GNS, HGSNAT, NAGLU, or SGSH), depending on the specific subtype of the disease. Because it follows an autosomal recessive inheritance pattern, an individual must inherit two copies of the mutated gene—one from each biological parent—to manifest the condition. Parents who carry only one copy of the mutation are known as "carriers" and typically do not show symptoms of Sanfilippo Syndrome themselves.

What is the risk of inheritance for siblings and future children?

When both biological parents are carriers of the gene mutation associated with Sanfilippo Syndrome, the statistical risks for each pregnancy are as follows:

• 25% chance that the child will inherit both mutated genes and develop the disease.


• 50% chance that the child will inherit one mutated gene and be an asymptomatic carrier like the parents.


• 25% chance that the child will inherit two normal genes and neither have the disease nor be a carrier.

Because the condition is inherited through these specific recessive patterns, de novo (spontaneous) mutations are extremely rare in Sanfilippo Syndrome. In the vast majority of cases, the condition is inherited from parents who were unaware they carried the recessive trait.

How is genetic testing and counseling utilized?

Genetic testing is the gold standard for diagnosing Sanfilippo Syndrome and is typically performed via a blood or saliva sample to identify mutations in the four genes linked to the condition. Genetic counseling is strongly recommended for families who have received a diagnosis or who have a family history of the disease. A genetic counselor can help interpret test results, calculate recurrence risks, and explain reproductive options, such as:

• Carrier testing: Identifying if relatives are carriers of the mutation.


• Prenatal diagnosis: Utilizing chorionic villus sampling (CVS) or amniocentesis during pregnancy to determine if the fetus is affected.


• Preimplantation Genetic Testing (PGT): Used in conjunction with IVF to screen embryos for the mutation before implantation.

Supporting the community

Navigating the genetic implications of Sanfilippo Syndrome can be emotionally taxing for families. At DiseaseMaps.org, we currently have 114 members who have been affected by or are living with Sanfilippo Syndrome, providing a space for shared experiences and support. Connecting with these families can provide both practical insights and emotional grounding as you navigate your medical journey.

Next steps

• Consult with a clinical geneticist to confirm the specific subtype of Sanfilippo Syndrome through molecular genetic testing.


• Request a referral to a genetic counselor to discuss family planning and testing for extended family members.


• Join the DiseaseMaps.org community to connect with other families navigating the complexities of this rare condition.


• Monitor updates from the National MPS Society regarding ongoing clinical trials for enzyme replacement and gene therapies.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD): Sanfilippo Syndrome


• Orphanet: Mucopolysaccharidosis type 3


• Online Mendelian Inheritance in Man (OMIM): MPS III Overview


• National MPS Society: Understanding MPS III